TTK Healthcare Limited (TTKHLTCARE.NS)
INR 1239.2
(-0.06%)
INR 1239.2
(-0.06%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 7.52 Billion INR | 3.82% |
| 2022 | 7.25 Billion INR | 21.65% |
| 2021 | 5.96 Billion INR | -5.9% |
| 2020 | 6.33 Billion INR | -1.74% |
| 2019 | 6.44 Billion INR | 2.95% |
| 2018 | 6.26 Billion INR | 8.72% |
| 2017 | 5.75 Billion INR | 8.62% |
| 2016 | 5.3 Billion INR | 3.0% |
| 2015 | 5.14 Billion INR | 6.68% |
| 2014 | 4.82 Billion INR | 16.12% |
| 2013 | 4.15 Billion INR | 8.81% |
| 2012 | 3.81 Billion INR | 7.96% |
| 2011 | 3.53 Billion INR | 14.01% |
| 2010 | 3.1 Billion INR | 23.03% |
| 2009 | 2.52 Billion INR | 14.82% |
| 2008 | 2.19 Billion INR | 10.35% |
| 2007 | 1.99 Billion INR | -5.73% |
| 2006 | 2.11 Billion INR | 13.17% |
| 2005 | 1.86 Billion INR | 21.94% |
| 2004 | 1.52 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.07 Billion INR | 14.83% |
| 2024 Q2 | 1.98 Billion INR | -4.53% |
| 2023 Q4 | 1.81 Billion INR | -1.52% |
| 2023 Q3 | 1.83 Billion INR | -1.03% |
| 2023 FY | 7.52 Billion INR | 3.82% |
| 2023 Q1 | 2.02 Billion INR | 12.21% |
| 2023 Q2 | 1.85 Billion INR | -8.09% |
| 2022 Q2 | 1.69 Billion INR | -11.85% |
| 2022 Q4 | 1.8 Billion INR | -1.33% |
| 2022 FY | 7.25 Billion INR | 21.65% |
| 2022 Q1 | 1.92 Billion INR | 2894.3% |
| 2022 Q3 | 1.82 Billion INR | 7.52% |
| 2021 Q2 | 2.06 Billion INR | 20.82% |
| 2021 Q1 | 1.7 Billion INR | -4.14% |
| 2021 Q3 | 2.12 Billion INR | 2.97% |
| 2021 FY | 5.96 Billion INR | -5.9% |
| 2021 Q4 | 64.32 Million INR | -96.97% |
| 2020 Q4 | 1.78 Billion INR | -0.57% |
| 2020 Q2 | 1.59 Billion INR | 37.17% |
| 2020 FY | 6.33 Billion INR | -1.74% |
| 2020 Q1 | 1.16 Billion INR | -14.03% |
| 2020 Q3 | 1.79 Billion INR | 12.23% |
| 2019 Q3 | 1.65 Billion INR | 0.58% |
| 2019 FY | 6.44 Billion INR | 2.95% |
| 2019 Q4 | 1.35 Billion INR | -18.34% |
| 2019 Q2 | 1.64 Billion INR | -7.69% |
| 2019 Q1 | 1.78 Billion INR | 29.51% |
| 2018 Q4 | 1.37 Billion INR | -7.48% |
| 2018 FY | 6.26 Billion INR | 8.72% |
| 2018 Q3 | 1.49 Billion INR | -10.27% |
| 2018 Q2 | 1.66 Billion INR | -4.06% |
| 2018 Q1 | 1.73 Billion INR | 19.31% |
| 2017 Q3 | 1.45 Billion INR | 2.23% |
| 2017 Q4 | 1.45 Billion INR | -0.61% |
| 2017 FY | 5.75 Billion INR | 8.62% |
| 2017 Q1 | 1.25 Billion INR | 7.41% |
| 2017 Q2 | 1.42 Billion INR | 13.92% |
| 2016 Q3 | 1.22 Billion INR | -9.91% |
| 2016 Q4 | 1.16 Billion INR | -5.02% |
| 2016 Q1 | 1.53 Billion INR | 32.56% |
| 2016 Q2 | 1.36 Billion INR | -10.93% |
| 2016 FY | 5.3 Billion INR | 3.0% |
| 2015 Q2 | 1.29 Billion INR | -6.42% |
| 2015 Q4 | 1.15 Billion INR | -11.66% |
| 2015 FY | 5.14 Billion INR | 6.68% |
| 2015 Q1 | 1.38 Billion INR | 24.34% |
| 2015 Q3 | 1.3 Billion INR | 0.79% |
| 2014 Q1 | 1.29 Billion INR | 29.82% |
| 2014 FY | 4.82 Billion INR | 16.12% |
| 2014 Q4 | 1.11 Billion INR | -7.7% |
| 2014 Q3 | 1.2 Billion INR | 0.37% |
| 2014 Q2 | 1.2 Billion INR | -7.23% |
| 2013 Q4 | 999.57 Million INR | -5.49% |
| 2013 FY | 4.15 Billion INR | 8.81% |
| 2013 Q3 | 1.05 Billion INR | 5.06% |
| 2013 Q2 | 1 Billion INR | -7.69% |
| 2013 Q1 | 1.09 Billion INR | 27.51% |
| 2012 FY | 3.81 Billion INR | 7.96% |
| 2012 Q2 | 954.27 Million INR | -12.04% |
| 2012 Q1 | 1.08 Billion INR | 23.18% |
| 2012 Q4 | 855.19 Million INR | -7.28% |
| 2012 Q3 | 922.32 Million INR | -3.35% |
| 2011 Q4 | 880.74 Million INR | 1.59% |
| 2011 Q3 | 867 Million INR | 0.0% |
| 2011 FY | 3.53 Billion INR | 14.01% |
| 2010 FY | 3.1 Billion INR | 23.03% |
| 2009 FY | 2.52 Billion INR | 14.82% |
| 2008 FY | 2.19 Billion INR | 10.35% |
| 2007 FY | 1.99 Billion INR | -5.73% |
| 2006 FY | 2.11 Billion INR | 13.17% |
| 2005 FY | 1.86 Billion INR | 21.94% |
| 2004 FY | 1.52 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Abbott India Limited | 58.48 Billion INR | 87.129% |
| Cipla Limited | 257.74 Billion INR | 97.079% |
| Gland Pharma Limited | 56.64 Billion INR | 86.711% |
| GlaxoSmithKline Pharmaceuticals Limited | 34.53 Billion INR | 78.203% |
| Kopran Limited | 6.14 Billion INR | -22.487% |
| Marksans Pharma Limited | 21.77 Billion INR | 65.427% |
| NGL Fine-Chem Limited | 3.38 Billion INR | -122.267% |
| Pfizer Limited | 21.93 Billion INR | 65.676% |
| Sanofi India Limited | 28.51 Billion INR | 73.596% |
| SMS Pharmaceuticals Limited | 7.09 Billion INR | -6.137% |